Journal of Experimental Medicine

The Journal of Experimental Medicine publishes immunology, cancer, stem cells, microbial pathogenesis, vascular biology, neurobiology. Est. 1896 - @RockUPress

[Journal of Experimental Medicine @JExpMed]

ICYMI: read the JEM #Cancer Collection highlighting the latest discoveries in the field of cancer #immunotherapy, anti-tumor #immunity, cancer #metabolism, #metastasis, and therapy resistance.
👉 https://t.co/tzd3Ey2sDG

[Journal of Experimental Medicine @JExpMed]

See a video summary of the study from the first author Gretchen Harms Pritchard:
https://t.co/bw4I5zSWvi

[Journal of Experimental Medicine @JExpMed]

Harms Pritchard, Pepper et al. @UW dissect key CD4⁺ T cell/B cell interactions to define signals that govern the development of memory B cell populations. https://t.co/pk0zHTsGnI

#InfectiousDisease #HostDefense #LymphocyteBiology #BCells

[Journal of Experimental Medicine @JExpMed]

tRNA m¹A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8⁺ T cells. From Shan Miao, Hao Li, Xiaohan Song, Youqiong Ye, Ru-Juan Liu, Hua-Bing Li et al. https://t.co/SHIaV6Rupr

📘 From JEM #Cancer Collection: https://t.co/91u4IT81rK
#EACR2026

[Journal of Experimental Medicine @JExpMed]

Read Sensing of metabolic signals via GPR183 promotes occupation of lung #macrophage niches by #monocytes https://t.co/80AJSPhgR2

[Journal of Experimental Medicine @JExpMed]

Publish your findings quicker through JEM manuscript transfers. “The handling of the transfer by the JEM editors and staff was excellent.” — Tim Willinger, JEM author https://t.co/R5DHQCvCyt

[Bhardwaj Lab @BhardwajLab]

Check out our latest review👏! We dive deep into how cDC1s orchestrate anti-tumor immunity through cross-presentation, immune networking, and spatial organization.

[Journal of Experimental Medicine @JExpMed]

Ward, Kar, Balan, and Bhardwaj @BhardwajLab review how conventional type 1 #DendriticCells (cDC1s) coordinate antitumor immunity through cross-presentation, immune cell networking, and spatial organization in tumors. https://t.co/A77oF770ZS

#CancerFocus #Immunotherapy

[Journal of Experimental Medicine @JExpMed]

Attending #FOCIS2026 in San Francisco? Do not miss 📃 the Late Breaking Abstract session TODAY June 10, 4pm-6pm! The session will be chaired by our Executive Editor Natalie Cain (@NatalieCainSci)!

[Journal of Experimental Medicine @JExpMed]

Regulatory T cells converted from Th1 cells in tumors suppress #cancer immunity via CD39. From Sang-Nee Tan, Chen Dong and colleagues: https://t.co/uEfuA898Og

📘 Part of JEM #Cancer Collection: https://t.co/Xe9KPETXQe
#EACR2026

[Journal of Experimental Medicine @JExpMed]

📢 #FOCIS2026 attendees: Join our Executive Editor Natalie Cain (@NatalieCainSci) TODAY for a "Meet the Editor" session, 11:45 am - 1:00 pm!

💡 Gain insights into the peer review process, and learn how to prepare a manuscript for publication and respond to reviewers’ comments!

[Journal of Experimental Medicine @JExpMed]

CD301b⁺ monocyte-derived dendritic cells mediate resistance to #radiotherapy (https://t.co/D0ZcKL7DgQ). From Sirimuvva Tadepalli, Derek Clements, Juliana Idoyaga @Idoyaga_Lab et al. https://t.co/y57PEOehMj

📘 Part of JEM #Cancer Collection: https://t.co/6SoQAGNpOP
#EACR2026

[Journal of Experimental Medicine @JExpMed]

Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting, from Aneesha Dasgupta, Jason Doles and colleagues: https://t.co/CAvCm5QboU

📘 Part of JEM #Cancer Collection: https://t.co/7Tz8irqH8J
#EACR2026

[Journal of Experimental Medicine @JExpMed]

This special collection, timed to coincide with #FOCIS2026 @FOCISimmunology, features recent and exciting advances in translational #immunology, including #InbornErrorsOfImmunity, #autoimmunity, #TumorImmunology, #immunotherapy, and #InfectiousDisease.
👉 https://t.co/xQhDN95oWP

[Journal of Experimental Medicine @JExpMed]

Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive #neuroblastoma, from Marie Ménard, Hiroyuki Yoda, William Weiss and colleagues: https://t.co/bRSkSRfAxt

📘 Part of JEM #Cancer Collection: https://t.co/gn01jKvsGA
#EACR2026

[MRicoteLab @MRicoteLab]

Do not miss this video by Laura Casablanca @CNB_CSIC, in which she explains the latest findings from our article published in @JExpMed. We have identified the transcrptional network that enables a #macrophage to acquire its #macrophage identity.

[Journal of Experimental Medicine @JExpMed]

Xiaoyun Li, Sofie Hedlund Møller, Ping-Chih Ho et al. show that tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor #macrophages: https://t.co/O4jOLj1rel

📘 Part of JEM #Cancer Collection: https://t.co/SI8T1qEIHE
#EACR2026

[Journal of Experimental Medicine @JExpMed]

📽️ New author video of a study by @MRicotelab @CNB_CSIC "A signal-responsive cooperative transcription factor network determines alveolar macrophage identity" (https://t.co/9kwyAcGwyT).
Video summary by Laura Casablanca: https://t.co/VjdaTbyLmn

[Journal of Experimental Medicine @JExpMed]

@MRicoteLab @CNIC_CARDIO @CNB_CSIC @nurcamein 📽️ See a short video summary of the study by Laura Casablanca:
https://t.co/iMUHdaT3pA

[Journal of Experimental Medicine @JExpMed]

Tissue-resident macrophages acquire distinct identities shaped by local signals. @MRicotelab et al. show that RXRs drive alveolar macrophage differentiation by regulating chromatin & gene expression in cooperation w other regulatory elements (1/2) https://t.co/cxwde33lZJ

[Journal of Experimental Medicine @JExpMed]

@MRicoteLab The first authors are Jorge Mínguez-Martínez and Jesús Porcuna @CNIC_CARDIO @CNB_CSIC @Nurcamein (2/2)

[Journal of Experimental Medicine @JExpMed]

Chimeric MHC class I and II-restricted non-self epitopes broaden anti-tumor T cell reactions. From Rongsheng Zhang, Tasuku Honjo, Kenji Chamoto and colleagues: https://t.co/4n8kiUXxWP

📘 Part of JEM #Cancer Collection: https://t.co/G4kZuFwhgu
#EACR2026